T-cell activation discriminates subclasses of symptomatic primary humoral immunodeficiency diseases in adults

BMC Immunology

Volumn 15, Issue 1, 2014, Pages

  Picat, Marie Quitterie ^a,b,c,d   Thiébaut, Rodolphe ^a,b,c,d   Lifermann, François ^e   Delbrel, Xavier ^f   Adoue, Daniel ^g   Wittkop, Linda ^a,b,c,d   Fauchais, Anne Laure ^h   Rispal, Patrick ⁱ   Moreau, Jean François ^b,c,j   Viallard, Jean François ^c,k  

^a INSERM   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c BORDEAUX UNIVERSITY HOSPITAL   (France)

^d INRIA SISTM   (France)

^e Department of Infectious Diseases Dax Hospital   (France)

^f Hospital of Pau   (France)

^g CHU PURPAN   (France)

^h DUPUYTREN UNIVERSITY HOSPITAL   (France)

ⁱ Department of Internal Medicine Agen Hospital   (France)

^j CNRS Bordeaux Segalen University   (France)

^k HAUT LÉVÊQUE HOSPITAL   (France)

more..

Author keywords

Common variable immunodeficiency; Good's syndrome; Hierarchical clustering; HLA DR marker; IgG subclass deficiency; Principal component analysis; Symptomatic primary humoral immunodeficiency; T cell activation

Indexed keywords

HLA DR ANTIGEN; CD8 ANTIGEN;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE ACTIVATION; CD8+ T LYMPHOCYTE; CHRONIC INFLAMMATION; CHRONIC INFLAMMATORY INTESTINAL DISEASE; COMMON VARIABLE IMMUNODEFICIENCY; CROSS-SECTIONAL STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; ENTERITIS; FEMALE; GOOD SYNDROME; GRANULOMATOSIS; HUMAN; HUMAN CELL; HUMORAL IMMUNE DEFICIENCY; IMMUNOGLOBULIN G DEFICIENCY; INTESTINE VILLUS ATROPHY; LYMPHOCYTE DIFFERENTIATION; LYMPHOID HYPERPLASIA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PROGNOSIS; SPLENOMEGALY; SYMPTOMATIC PRIMARY HUMORAL IMMUNODEFICIENCY DISEASE; T LYMPHOCYTE ACTIVATION; ADULT DISEASE; CHRONIC DISEASE; COHORT ANALYSIS; DENDRITIC CELL; ENTEROPATHY; FLOW CYTOMETRY; IMMUNE DEFICIENCY; IMMUNOLOGICAL PARAMETERS; INFLAMMATORY DISEASE; MEMORY CELL; NATURAL KILLER CELL; PRIMARY HUMORAL IMMUNODEFICIENCY DISEASE;

ADULT; B-LYMPHOCYTES; BIOLOGICAL MARKERS; CLUSTER ANALYSIS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; IMMUNITY, INNATE; IMMUNOGLOBULIN ISOTYPES; IMMUNOLOGIC DEFICIENCY SYNDROMES; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; SENSITIVITY AND SPECIFICITY; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES;

EID: 84899113812     PISSN: None     EISSN: 14712172     Source Type: Journal    
DOI: 10.1186/1471-2172-15-13     Document Type: Article

References (36)

1. Al-Herz W, Bousfiha A, Casanova JL, Chapel H, Conley ME, Cunningham-Rundles C, Etzioni A, Fischer A, Franco JL, Geha RS, Hammarström L, Nonoyama S, Notarangelo LD, Ochs HD, Puck JM, Roifman CM, Seger R, Tang ML. Primary immunodeficiency diseases: an update on the classification from the international union of immunological societies expert committee for primary immunodeficiency. Front Immunol 2011, 2:54. 3342372, 22566844.
2. Oksenhendler E, Gerard L, Fieschi C, Malphettes M, Mouillot G, Jaussaud R, Viallard JF, Gardembas M, Galicier L, Schleinitz N, Suarez F, Soulas-Sprauel P, Hachulla E, Jaccard A, Gardeur A, Théodorou I, Rabian C, Debré P, Viallard JF, Gardembas M, Galicier L, Schleinitz N, Suarez F, Soulas-Sprauel P, Hachulla E, Jaccard A, Gardeur A, Théodorou I, Rabian C, et al. DEFI Study Group Infections in 252 patients with common variable immunodeficiency. Clin Infect Dis 2008, 46(10):1547-1554. 10.1086/587669, 18419489, DEFI Study Group.
3. Preud'homme JL, Hanson LA. IgG subclass deficiency. Immunodefic Rev 1990, 2(2):129-149.
4. Kelesidis T, Yang O. Good's syndrome remains a mystery after 55 years: a systematic review of the scientific evidence. Clin Immunol 2010, 135:347-363. 10.1016/j.clim.2010.01.006, 20149753.
5. Wehr C, Kivioja T, Schmitt C, Ferry B, Witte T, Eren E, Vlkova M, Hernandez M, Detkova D, Bos PR, Poerksen G, von Bernuth H, Baumann U, Gutenberger S, Schlesier M, Bergeron-van der Cruyssen F, Le Garff M, Debré P, Jacobs R, Jones J, Bateman E, Litzman J, van Hagen PM, Plebani A, Schmidt RE, Thon V, Quinti I, Espanol T, Webster AD, Chapel H, et al. The EUROclass trial: defining subgroups in common variable immunodeficiency. Blood 2008, 111(1):77-85. 10.1182/blood-2007-06-091744, 17898316.
6. Chapel H, Lucas M, Lee M, Bjorkander J, Webster D, Grimbacher B, Fieschi C, Thon V, Abedi MR, Hammarstrom L. Common variable immunodeficiency disorders: division into distinct clinical phenotypes. Blood 2008, 112(2):277-286. 10.1182/blood-2007-11-124545, 18319398.
7. Mouillot G, Carmagnat M, Gerard L, Garnier JL, Fieschi C, Vince N, Karlin L, Viallard JF, Jaussaud R, Boileau J, Donadieu J, Gardembas M, Schleinitz N, Suarez F, Hachulla E, Delavigne K, Morisset M, Jacquot S, Just N, Galicier L, Charron D, Debré P, Oksenhendler E, Rabian C, DEFI Study Group B-cell and T-cell phenotypes in CVID patients correlate with the clinical phenotype of the disease. J Clin Immunol 2010, 30(5):746-755. 10.1007/s10875-010-9424-3, 20437084, DEFI Study Group.
8. Cunningham-Rundles C. How I, treat common variable immune deficiency. Blood 2010, 116(1):7-15. 10.1182/blood-2010-01-254417, 2904582, 20332369.
9. Piqueras B, Lavenu-Bombled C, Bergeron-van der Cruyssen F, Mouthon L, Chevret S, Debré P, Schmitt C, Oksenhendler E. Common variable immunodeficiency patient classification based on impaired B cell memory differentiation correlates with clinical aspects. J Clin Immunol 2003, 23(5):385-400. 10.1023/A:1025373601374, 14601647.
10. Warnatz K, Denz A, Drager R, Braun M, Groth C, Wolff-Vorbeck G, Eibel H, Schlesier M, Peter HH. Severe deficiency of switched memory B cells (CD27(+)IgM(-)IgD(-)) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease. Blood 2002, 99(5):1544-1551. 10.1182/blood.V99.5.1544, 11861266.
11. Giovannetti A, Pierdominici M, Mazzetta F, Marziali M, Renzi C, Mileo AM, De Felice M, Mora B, Esposito A, Carello R, Pizzuti A, Paggi MG, Paganelli R, Malorni W, Aiuti F. Unravelling the complexity of T cell abnormalities in common variable immunodeficiency. J Immunol 2007, 178(6):3932-3943.
12. Viallard JF, Blanco P, Andre M, Etienne G, Liferman F, Neau D, Vidal E, Moreau JF, Pellegrin JL. CD8 + HLA-DR + T lymphocytes are increased in common variable immunodeficiency patients with impaired memory B-cell differentiation. Clin Immunol 2006, 119(1):51-58. 10.1016/j.clim.2005.11.011, 16413828.
13. Rezaei N, Wing JB, Aghamohammadi A, Carlring J, Lees A, Asgarian-Omran H, Pourpak Z, Sarrafnejad A, Kardar GA, Shahrestani T, Masoumi F, Zare A, Saghafi S, Sarrafzadeh S, Foster RA, Heath AW, Read RC. B-cell-T-cell activation and interaction in common variable immunodeficiency. Hum Immunol 2010, 71(4):355-362. 10.1016/j.humimm.2010.01.019, 20097245.
14. Fevang B, Yndestad A, Sandberg WJ, Holm AM, Muller F, Aukrust P, Frøland SS. Low numbers of regulatory T cells in common variable immunodeficiency: association with chronic inflammation in vivo. Clin Exp Immunol 2007, 147(3):521-525. 10.1111/j.1365-2249.2006.03314.x, 1810487, 17302902.
15. Horn J, Manguiat A, Berglund LJ, Knerr V, Tahami F, Grimbacher B, Fulcher DA. Decrease in phenotypic regulatory T cells in subsets of patients with common variable immunodeficiency. Clin Exp Immunol 2009, 156(3):446-454. 10.1111/j.1365-2249.2009.03913.x, 2691973, 19438597.
16. Viallard JF, Bloch-Michel C, Caubet O, Parrens M, Texier-Maugein J, Neau-Cransac M, Taupin JL, Moreau JF, Pellegrin JL. Gammadelta T lymphocytosis associated with granulomatous disease in a patient with common variable immunodeficiency. Clin Infect Dis 2002, 35(12):134-137.
17. Fulcher DA, Avery DT, Fewings NL. Invariant natural killer (iNK) T cell deficiency in patients with common variable immunodeficiency. Clin Exp Immunol 2009, 157(3):365-369. 10.1111/j.1365-2249.2009.03973.x, 2745030, 19664144.
18. Scott-Taylor TH, Green MR, Raeiszadeh M, Workman S, Webster AD. Defective maturation of dendritic cells in common variable immunodeficiency. Clin Exp Immunol 2006, 145(3):420-427. 10.1111/j.1365-2249.2006.03152.x, 1809697, 16907909.
19. Garg V, Lipka S, Rizvon K, Singh J, Rashid S, Mustacchia P. Diffuse nodular lymphoid hyperplasia of intestine in selective IgG 2 subclass deficiency, autoimmune thyroiditis, and autoimmune hemolytic anemia: case report and literature review. J Gastrointestinal Liver Dis 2012, 21(4):431-434.
20. Park MA, Li JT, Hagan JB, Maddox DE, Abraham RS. Common variable immunodeficiency: a new look at an old disease. Lancet 2008, 372(9637):489-502. 10.1016/S0140-6736(08)61199-X, 18692715.
21. Aghamohammadi A, Parvaneh N, Rezaei N. Common variable immunodeficiency: a heterogeneous group needs further subclassification. Expert Rev Clin Immunol 2009, 5(6):629-631. 10.1586/eci.09.65, 20477686.
22. O'Gorman MR, Zollett J, Bensen N. Flow cytometry assays in primary immunodeficiency diseases. Methods Mol Biol 2011, 699:317-335. 10.1007/978-1-61737-950-5_15, 21116990.
23. Lugli E, Roederer M, Cossarizza A. Data analysis in flow cytometry: the future just started. Cytometry A 2010, 77(7):705-713. 2909632, 20583274.
24. Lugli E, Pinti M, Nasi M, Troiano L, Ferraresi R, Mussi C, Salvioli G, Patsekin V, Robinson JP, Durante C, Cocchi M, Cossarizza A. Subject classification obtained by cluster analysis and principal component analysis applied to flow cytometric data. Cytometry A 2007, 71(5):334-344.
25. Ringner M. What is principal component analysis?. Nat Biotechnol 2008, 26(3):303-304. 10.1038/nbt0308-303, 18327243.
26. Everitt B. Cluster analysis is a generic term for a wide range of numerical methods for examining data. Stat Methods Med Res 2004, 13(5):343-345. 10.1191/0962280204sm371ed, 15516029.
27. Ward J. Hierarchical grouping to optimize an objective function. J Am Stat Assoc 1963, 58(301):236-244.
28. Giovannetti A, Pierdominici M, Aiuti F. T-cell homeostasis: the dark(ened) side of common variable immunodeficiency. Blood 2008, 112(2):446.
29. Pencina MJ, D'Agostino RB, D'Agostino RB, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 2008, 27(2):157-172. 10.1002/sim.2929, 17569110.
30. Focosi D, Bestagno M, Burrone O, Petrini M. CD57+ T lymphocytes and functional immune deficiency. J Leukoc Biol 2010, 87(1):107-116. 10.1189/jlb.0809566, 19880576.
31. Yong PF, Thaventhiran JE, Grimbacher B. "A rose is a rose is a rose," but CVID is not CVID common variable immune deficiency (CVID), what do we know in 2011?. Adv Immunol 2011, 111:47-107.
32. Vlková M, Thon V, Sárfyová M, Bláha L, Svobodník A, Lokaj J, Litzman J. Age dependency and mutual relations in T and B lymphocyte abnormalities in common variable immunodeficiency patients. Clin Exp Immunol 2006, 143(2):373-379. 10.1111/j.1365-2249.2006.02999.x, 1809591, 16412063.
33. Su LF, Kidd BA, Han A, Kotzin JJ, Davis MM. Virus-specific CD4(+) memory-phenotype T cells are abundant in unexposed adults. Immunity 2013, 38(2):373-383. 10.1016/j.immuni.2012.10.021, 3626102, 23395677.
34. Guerri L, Dusseaux M, Martin E, Soudais C, Lantz O. Mucosal-associated invariant T cells: unconventional development and function. Trends Immunol 2011, 32(5):212-218. 10.1016/j.it.2011.02.005, 21459674.
35. Young MH, U'ren L, Huang S, Mallevaey T, Scott-Browne J, Crawford F, Lantz O, Hansen TH, Kappler J, Marrack P, Gapin L. MAIT cell recognition of MR1 on bacterially infected and uninfected cells. PLoS One 2013, 8(1):e53789. 10.1371/journal.pone.0053789, 3544856, 23342002.
36. Litzman J, Nechvatalova J, Xu J, Ticha O, Vlkova M, Hel Z. Chronic immune activation in common variable immunodeficiency (CVID) is associated with elevated serum levels of soluble CD14 and CD25 but not endotoxaemia. Clin Exp Immunol 2012, 170:321-332. 10.1111/j.1365-2249.2012.04655.x, 3518892, 23121673.